Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Heartbeam Inc (BEAT)

Heartbeam Inc (BEAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
HeartBeam (NASDAQ: BEAT) Presents Key Data in Presentation of Proprietary HeartBeam AI Investor Brand Network - Wed Apr 10, 8:38AM CDT

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is presenting new data at the European Heart Rhythm Association (“EHRA”)...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023 Investor Brand Network - Fri Mar 22, 9:42AM CDT

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its financial numbers and operational highlights for...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing AIMIGo(TM) Investor Brand Network - Fri Mar 15, 8:59AM CDT

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has begun enrolling the first patients in its VALID-ECG pivotal study....

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Awarded Two US Patents Covering Core Cardiac Monitoring Tech Investor Brand Network - Fri Mar 8, 10:39AM CST

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has received notification that two of its patents covering core vectorelectrocardiography...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) to Host Q4 and FY 2023 Results Call Investor Brand Network - Wed Mar 6, 9:46AM CST

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced that it will hold a conference call to discuss its...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Combines AI, Proprietary Tech to Deliver Cardiac Insights Investor Brand Network - Fri Dec 15, 2023

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced significant developments for the use of artificial...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Releases Q3 2023 Financial Report, Operational Update Investor Brand Network - Thu Nov 16, 2023

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, allowing for the...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Expands Scientific Advisory Board Investor Brand Network - Fri Nov 10, 2023

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, today announced...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) to Host Third Quarter 2023 Results Conference Call Investor Brand Network - Wed Nov 1, 2023

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home, announced that it...

BEAT : 2.05 (+0.49%)
HeartBeam (NASDAQ: BEAT) Names Experienced Leaders to New Senior Management Positions Investor Brand Network - Wed Sep 27, 2023

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram (“VECG”) platform for patient use at home allowing for the...

AAPL : 169.02 (+1.27%)
BEAT : 2.05 (+0.49%)

Barchart Exclusives

Is This Pullback Your Best Chance to Buy Nvidia Stock? Barchart - 20 minutes ago
As Nvidia experiences a pullback of approximately 18% from its recent highs, investors might be contemplating whether this presents an opportune moment to scoop up the stock. With concerns about valuation easing and analysts growing more bullish, this analysis explores whether now is the optimal time to consider investing in Nvidia. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot